Axxion S.A.’s Boston Scientific BSX Stock Holding History

Axxion S.A.’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$864K	Buy	+20,236	New	+$1.1M	0.06%	167

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Axxion S.A.'s BSX Position: Q2 2026 in Review

Axxion S.A. opened a new position in Boston Scientific (BSX) in Q2 2026: 20,236 shares worth $864K. The stake represents 0.06% of the portfolio and ranks #167 among its holdings.

1,330 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Axxion S.A. held 20,236 shares of Boston Scientific worth $864K as of Q2 2026.
Boston Scientific was a new Axxion S.A. position in Q2 2026.
Boston Scientific made up 0.06% of Axxion S.A.'s portfolio in Q2 2026, its #167 holding.
1,330 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Axxion S.A.'s 13F filing for Q2 2026, filed 14 Aug 2026.